| 000 | 01602 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513213702.0 | ||
| 264 | 0 | _c20000720 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1054/bjoc.2000.1164 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPujol, J L | |
| 245 | 0 | 0 |
_aIs there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cJul 2000 |
||
| 300 |
_a8-15 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Meta-Analysis | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCarestia, L | |
| 700 | 1 | _aDaurès, J P | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 83 _gno. 1 _gp. 8-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1054/bjoc.2000.1164 _zAvailable from publisher's website |
| 999 |
_c10834173 _d10834173 |
||